(IAK) iShares U.S. Insurance - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642887867
IAK: Insurance, Stocks, U.S. Financial Securities
The iShares U.S. Insurance ETF (NYSE ARCA: IAK) is designed to track the performance of the U.S. insurance sector by investing primarily in the component securities of its underlying index. The fund allocates at least 80% of its assets to these securities or to investments with similar economic characteristics. Additionally, it may utilize derivatives such as futures, options, and swap contracts to enhance tracking accuracy or manage risk. The fund also has the flexibility to hold up to 20% of its assets in cash, cash equivalents, or other securities not included in the index, provided they align with the funds objective. As a non-diversified fund, it can concentrate its holdings in a smaller number of securities, which may amplify exposure to sector-specific risks and opportunities.
From a technical perspective, IAK is currently trading above its 20-day and 50-day moving averages, with the last price of 134.16 exceeding the SMA 20 (130.37) and SMA 50 (132.54). This suggests positive momentum in the short to medium term. The SMA 200 (127.74) also indicates an upward trend over the longer term. The Average True Range (ATR) of 3.33 reflects moderate volatility, suggesting that price movements are manageable. On the fundamental side, the funds assets under management (AUM) of $741.02 million signal a robust investor base, contributing to liquidity. Based on these technical and fundamental factors, IAK is likely to maintain its upward trajectory, supported by the strength of the U.S. insurance sector and the funds ability to track its underlying index effectively.
Additional Sources for IAK ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IAK ETF Overview
Market Cap in USD | 828m |
Category | Financial |
TER | 0.40% |
IPO / Inception | 2006-05-01 |
IAK ETF Ratings
Growth Rating | 90.2 |
Fundamental | - |
Dividend Rating | 50.0 |
Rel. Strength | -5.41 |
Analysts | - |
Fair Price Momentum | 142.59 USD |
Fair Price DCF | - |
IAK Dividends
Dividend Yield 12m | 1.57% |
Yield on Cost 5y | 4.02% |
Annual Growth 5y | 6.25% |
Payout Consistency | 94.1% |
Payout Ratio | % |
IAK Growth Ratios
Growth Correlation 3m | 5.4% |
Growth Correlation 12m | 77.7% |
Growth Correlation 5y | 97.3% |
CAGR 5y | 21.03% |
CAGR/Max DD 5y | 1.42 |
Sharpe Ratio 12m | 1.23 |
Alpha | 9.61 |
Beta | 0.603 |
Volatility | 17.94% |
Current Volume | 58.5k |
Average Volume 20d | 72.3k |
As of June 20, 2025, the stock is trading at USD 131.11 with a total of 58,500 shares traded.
Over the past week, the price has changed by -1.49%, over one month by -4.48%, over three months by -2.54% and over the past year by +16.28%.
Yes. Based on ValueRay´s Analyses, iShares U.S. Insurance (NYSE ARCA:IAK) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 90.18 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IAK is around 142.59 USD . This means that IAK is currently overvalued and has a potential downside of 8.76%.
iShares U.S. Insurance has no consensus analysts rating.
According to our own proprietary Forecast Model, IAK iShares U.S. Insurance will be worth about 158 in June 2026. The stock is currently trading at 131.11. This means that the stock has a potential upside of +20.48%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 158 | 20.5% |